Advancing evidence-based treatment of infectious diseases in children with real-world data: Opportunities and...

Area of Science:

• Pediatric pharmacology
• Infectious disease research
• Real-world data (RWD) utilization

Background:

• Significant use of off-label medications in pediatric care due to limited pediatric-specific trial data.
• Abundance of real-world data from routine clinical practice in children.
• Underutilization of real-world data, including electronic health records, in pediatric infectious disease research.

Purpose of the Study:

• To explore the potential of real-world data (RWD) in advancing pediatric medicine.
• To identify opportunities and challenges for using RWD in pediatric infectious disease research.
• To generate evidence for optimal treatment and management strategies in pediatric infectious diseases.

Main Methods:

• Discussion of opportunities and challenges in applying real-world data (RWD) to pediatric infectious diseases.
• Analysis of existing clinical practice data for pediatric drug use.
• Review of literature on real-world data in pharmaceutical research.

Main Results:

• Real-world data (RWD) presents a significant opportunity to address the evidence gap in pediatric medicine.
• Challenges exist in applying RWD, particularly in specialized areas like pediatric infectious diseases.
• Potential for RWD to inform treatment guidelines and regulatory decisions for children's medications.

Conclusions:

• Real-world data (RWD) holds promise for improving the evidence base for pediatric medicines, especially infectious disease treatments.
• Overcoming challenges in RWD implementation is key to realizing its full potential in pediatric research.
• Further research and data infrastructure are needed to effectively leverage RWD for children's health outcomes.